CP
Camelot Portfolios’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-222
| Closed | -$6.2K | – | 443 |
|
|
2024
Q2 | $6.2K | Buy |
+222
| New | +$6.2K | ﹤0.01% | 451 |
|
|
2018
Q2 | – | Sell |
-7,431
| Closed | -$263K | – | 219 |
|
|
2018
Q1 | $263K | Buy |
7,431
+58
| +0.8% | +$2.05K | 0.12% | 157 |
|
|
2017
Q4 | $267K | Sell |
7,373
-29
| -0.4% | -$1.05K | 0.13% | 137 |
|
|
2017
Q3 | $264K | Sell |
7,402
-66
| -0.9% | -$2.35K | 0.13% | 139 |
|
|
2017
Q2 | $251K | Sell |
7,468
-8,597
| -54% | -$289K | 0.12% | 145 |
|
|
2017
Q1 | $550K | Sell |
16,065
-797
| -5% | -$27.3K | 0.27% | 98 |
|
|
2016
Q4 | $548K | Sell |
16,862
-2,223
| -12% | -$72.2K | 0.29% | 93 |
|
|
2016
Q3 | $646K | Buy |
+19,085
| New | +$646K | 0.35% | 85 |
|
|
2015
Q3 | – | Sell |
-8,524
| Closed | -$286K | – | 168 |
|
|
2015
Q2 | $286K | Sell |
8,524
-764
| -8% | -$25.6K | 0.16% | 128 |
|
|
2015
Q1 | $323K | Sell |
9,288
-25,566
| -73% | -$889K | 0.19% | 125 |
|
|
2014
Q4 | $1.09M | Sell |
34,854
-127
| -0.4% | -$3.96K | 0.62% | 47 |
|
|
2014
Q3 | $1.03M | Buy |
34,981
+2,093
| +6% | +$61.9K | 0.6% | 44 |
|
|
2014
Q2 | $976K | Buy |
32,888
+7,442
| +29% | +$221K | 0.63% | 49 |
|
|
2014
Q1 | $817K | Sell |
25,446
-10,630
| -29% | -$341K | 0.55% | 54 |
|
|
2013
Q4 | $1.11M | Sell |
36,076
-4,467
| -11% | -$137K | 0.71% | 33 |
|
|
2013
Q3 | $1.17M | Buy |
40,543
+1,099
| +3% | +$31.6K | 0.85% | 30 |
|
|
2013
Q2 | $1.11M | Buy |
+39,444
| New | +$1.11M | 0.84% | 34 |
|